These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38983507)

  • 1. A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics.
    Gjølberg TT; Lode HE; Melo GB; Mester S; Probst C; Sivertsen MS; Jørstad ØK; Andersen JT; Moe MC
    Front Ophthalmol (Lausanne); 2022; 2():882013. PubMed ID: 38983507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes.
    Lode HE; Gjølberg TT; Foss S; Sivertsen MS; Brustugun J; Andersson Y; Jørstad ØK; Moe MC; Andersen JT
    Sci Rep; 2019 Dec; 9(1):18021. PubMed ID: 31792234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicone oil droplets in repackaged anti-vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination.
    Olea JL; Gómez-Resa M; Cervera-Peris MM; Aragón JA
    Eur J Ophthalmol; 2020 Jul; 30(4):774-779. PubMed ID: 30642195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study of Silicone Oil Microdroplets in Eyes Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in 3 Different Syringes.
    Thompson JT
    Ophthalmol Retina; 2021 Mar; 5(3):234-240. PubMed ID: 32735904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection.
    Melo GB; da Cruz NFS; do Monte Agra LL; Emerson GG; Lima LH; Linkuviene V; Maia M; Farah ME; Carpenter JF; Rodrigues EB; Probst C
    Acta Ophthalmol; 2021 Dec; 99(8):e1366-e1374. PubMed ID: 33890418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review.
    Uzzan J; Mapani A; Cox O; Bagijn M; Saffar I
    Ophthalmol Ther; 2024 Sep; 13(9):2445-2465. PubMed ID: 39066961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
    Khurana RN; Chang LK; Porco TC
    JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study.
    Sivertsen MS; Lode HE; Gjølberg TT; Petrovski G; Andersen JT; Jørstad ØK; Moe MC
    BMJ Open Ophthalmol; 2021; 6(1):e000764. PubMed ID: 34485702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
    Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
    PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
    Jørstad ØK; Foss S; Gjølberg TT; Mester S; Nyquist-Andersen M; Sivertsen MS; Fossum D; Gleditsch E; Moe MC; Andersen JT
    Int J Retina Vitreous; 2023 Nov; 9(1):65. PubMed ID: 37936232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the initial level and migration of silicone oil lubricant in empty prefilled syringes for biologics using infrared spectroscopy.
    Bee JS; Frey VV; Javed U; Chung J; Corcoran ML; Roussel PS; Krause SO; Cash PW; Bishop SM; Dimitrova MN
    PDA J Pharm Sci Technol; 2014; 68(5):494-503. PubMed ID: 25336420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deformation of Aflibercept and Ranibizumab Syringes Causes Variation in Intravitreal Injection Volume and Risks Retinal Tear Formation.
    Raevis JJ; Lemire CA; Ramsey DJ; Riccobono J; Gonzalez E
    Ophthalmol Sci; 2022 Dec; 2(4):100202. PubMed ID: 36531591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of silicone oil droplets from syringes.
    Melo GB; Dias Junior CS; Carvalho MR; Cardoso AL; Morais FB; Figueira ACM; Lima Filho AAS; Emerson GG; Maia M
    Int J Retina Vitreous; 2019; 5():1. PubMed ID: 30788149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefilled syringes for intravitreal drug delivery.
    Sassalos TM; Paulus YM
    Clin Ophthalmol; 2019; 13():701-706. PubMed ID: 31114147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents.
    Finkelstein M; Katz G; Zur D; Rubowitz A; Moisseiev E
    Ophthalmologica; 2022; 245(1):34-40. PubMed ID: 34348344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF.
    García SB; Garrell-Salat X; Trejo-Velasco F; Aragón-Roca D; Zapata MÁ; García-Arumí J
    BMC Ophthalmol; 2022 Jul; 22(1):319. PubMed ID: 35883113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals.
    Antoszyk AN; Baker C; Calzada J; Cummings H; So J; Quezada-Ruiz C; Haskova Z
    PDA J Pharm Sci Technol; 2018; 72(4):411-419. PubMed ID: 29853609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Novel Prefilled Syringe Concept for Ophthalmic Applications: A Formative Human Factors Study.
    Franzese C; Takeuchi K; Carabello H; Thomas C; Nakamura K; Kalbermatten A; Bajars E; Coyne M
    PDA J Pharm Sci Technol; 2022; 76(1):19-33. PubMed ID: 34131016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents.
    Moisseiev E; Rudell J; Tieu EV; Yiu G
    Curr Eye Res; 2017 Jul; 42(7):1059-1063. PubMed ID: 28306392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS.
    Krauthammer M; Harel G; Moisseiev E
    Retina; 2023 Mar; 43(3):514-519. PubMed ID: 36729828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.